8-K: Ingredion Reports Strong Q4 and Full-Year 2023 Results, Exceeding $1 Billion in Cash from Operations

Ingredion's fourth quarter and full-year 2023 results showed significant growth in operating income and earnings per share, driven by strategic pricing and cost management.

Summary

• Ingredion reported a strong performance for both the fourth quarter and full year of 2023.
• Fourth quarter reported and adjusted operating income increased by 29% and 21%, respectively.
• Full-year reported and adjusted EPS were $9.60 and $9.42, respectively, representing increases of 31% and 26%.
• These EPS figures include a contribution of $0.47 and $0.45, respectively, from the S. Korea business.
• Cash from operations for the full year reached $1,057 million, a significant increase from $152 million in 2022.
• The company returned $295 million to shareholders through dividends and share repurchases.
• Net sales for the full year were $8.16 billion, a 3% increase compared to the previous year.
• The company expects full-year 2024 reported EPS to be between $10.20 and $11.15 and adjusted EPS to be between $9.15 and $9.85, reflecting the divestiture of the S. Korea business.

Sentiment

Score: 8

Explanation: The document conveys a strong positive sentiment due to the significant improvements in operating income, EPS, and cash flow. The company's strategic actions and future outlook are also presented optimistically, although there are some challenges noted.

Positives

• Ingredion demonstrated strong operating income growth, exceeding 20% for both the fourth quarter and full year.
• The company's targeted pricing actions and cost savings initiatives effectively mitigated the impact of inflation and raw material volatility.
• Gross margin expanded for the sixth consecutive quarter.
• Cash from operations exceeded $1 billion, indicating strong cash flow generation.
• The company successfully returned a significant amount of capital to shareholders.
• Ingredion's diversified portfolio of ingredients and solutions continues to strengthen.
• The company is well-positioned for profitable growth and margin expansion in 2024.
• The reorganization of business operations is expected to better align resources with customer needs.

Negatives

• Fourth quarter net sales decreased by 3% due to volume declines, although this was partially offset by price mix and foreign exchange impacts.
• Full-year net sales were impacted by volume declines and foreign exchange impacts, although price mix contributed to a 3% increase.
• South America experienced a decrease in full-year operating income due to lower volumes and higher energy costs.
• The company expects net sales to be down mid-single-digits in the first quarter of 2024.
• Reported and adjusted operating income are expected to be down 25-35% in the first quarter of 2024, including the impact of the Argentina peso devaluation.

Risks

• The company faces risks related to global economic conditions, which could affect customer demand and pricing.
• Fluctuations in raw material and energy costs, as well as supply chain disruptions, could impact profitability.
• The company is exposed to foreign exchange risks, which can affect sales and operating income.
• The company's performance is subject to the acceptance of products developed through genetic modification and biotechnology.
• The company faces competition in the corn-refining industry and related markets.
• The company's ability to achieve expected synergies from acquisitions and strategic alliances is not guaranteed.
• The company is exposed to risks associated with operating in foreign countries and in foreign currencies.
• The company's future performance is subject to various risks and uncertainties, including those related to climate change, legal and regulatory compliance, and security breaches.

Future Outlook

The company expects full-year 2024 reported EPS to be in the range of $10.20 to $11.15 and adjusted EPS to be in the range of $9.15 to $9.85, reflecting the impact of the S. Korea business divestiture. Excluding the effects of the divestiture, the company expects full-year 2024 net sales to be flat to up low single-digits and adjusted operating income to be up mid-single-digits. Cash from operations for full-year 2024 is expected to be in the range of $750 million to $900 million. Capital expenditures for the full year are expected to be approximately $340 million. For the first quarter of 2024, the company expects net sales to be down mid-single-digits and reported and adjusted operating income to be down 25-35%.

Management Comments

• Jim Zallie, Ingredion's president and CEO, stated that the business performed exceptionally well and remained resilient throughout 2023, delivering more than 20% operating income growth for both the fourth quarter and full year.
• Zallie noted that targeted pricing actions and proactive cost savings initiatives helped overcome inflation and raw material volatility.
• Zallie also mentioned that cash from operations exceeded $1 billion and the company returned $295 million to shareholders.
• Zallie expressed confidence that the reorganization of business operations will better align resources and capabilities with customer needs to better target growth opportunities.
• Zallie believes the Driving Growth Roadmap continues to guide long-term value creation for shareholders.

Industry Context

Ingredion's strong performance reflects a positive trend in the ingredient solutions sector, where companies are focusing on cost management and strategic pricing to navigate economic challenges. The company's emphasis on specialty ingredients and innovation aligns with the broader industry shift towards value-added products and solutions. The divestiture of the S. Korea business is a strategic move to optimize the company's portfolio and focus on core growth areas.

Comparison to Industry Standards

• Ingredion's 26% increase in adjusted EPS for 2023 is a strong result compared to some of its peers in the food and beverage ingredient sector. For example, companies like ADM and Tate & Lyle have also reported positive results, but Ingredion's growth rate is notable.
• The $1.057 billion in cash from operations is a significant improvement and places Ingredion in a strong position compared to companies that have struggled with cash flow in the same period.
• The company's focus on cost management and margin expansion is a common theme in the industry, but Ingredion's ability to achieve six consecutive quarters of gross margin expansion is a standout achievement.
• While some competitors may have seen higher volume growth in certain segments, Ingredion's performance in specialty ingredients and its ability to recover volumes in the second half of the year are positive indicators.
• The divestiture of the S. Korea business is a strategic move that aligns with industry trends of portfolio optimization and focusing on core growth areas, similar to actions taken by other companies in the sector.

Stakeholder Impact

• Shareholders will benefit from increased earnings per share, dividends, and share repurchases.
• Employees may experience changes due to the reorganization of business operations.
• Customers will benefit from the company's focus on aligning resources with their needs.
• Suppliers may see changes in demand based on the company's production schedules and inventory levels.
• Creditors will be reassured by the company's strong cash flow and financial performance.

Next Steps

• The company will continue to focus on its Driving Growth Roadmap to create long-term value for shareholders.
• Ingredion will work to better align its resources and capabilities with customer needs through the reorganization of its business operations.
• The company will focus on delivering profitable growth and margin expansion, as well as generating strong cash flow.
• Ingredion will continue to deepen customer relationships and drive innovation and operational excellence.
• The company will host a conference call on February 6, 2024, to discuss the fourth quarter and year-end financial results.

Key Dates

Keywords

Ingredion, ingredient solutions, financial results, operating income, earnings per share, net sales, cash flow, shareholder return, specialty ingredients, cost savings, pricing actions, divestiture, S. Korea business